Literature DB >> 27699970

Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.

José E Vidal1,2,3, Carolina Toniolo1, Adriana Paulino1, Arnaldo Colombo4, Marilena Dos Anjos Martins5, Cristina da Silva Meira5, Vera Lucia Pereira-Chioccola5, Claudia Figueiredo-Mello1,6, Tiago Barros1, Jequelie Duarte1, Fernanda Fonseca1, Mirella Alves Cunha1, Clara Mendes1, Taiana Ribero1, Marcia Dos Santos Lazera7, Radha Rajasingham8, David R Boulware8.   

Abstract

OBJECTIVE: To determine the prevalence of asymptomatic cryptococcal antigen (CRAG) using lateral flow assay (LFA) in hospitalised HIV-infected patients with CD4 counts <200 cells/μl.
METHODS: Hospitalised HIV-infected patients were prospectively recruited at Instituto de Infectologia Emilio Ribas, a tertiary referral hospital to HIV-infected patients serving the São Paulo State, Brazil. All patients were >18 years old without prior cryptococcal meningitis, without clinical suspicion of cryptococcal meningitis, regardless of antiretroviral (ART) status, and with CD4 counts <200 cells/μl. Serum CRAG was tested by LFA in all patients, and whole blood CRAG was tested by LFA in positive cases.
RESULTS: We enrolled 163 participants of whom 61% were men. The duration of HIV diagnosis was a median of 8 (range, 1-29) years. 26% were antiretroviral (ART)-naïve, and 74% were ART-experienced. The median CD4 cell count was 25 (range, 1-192) cells/μl. Five patients (3.1%; 95%CI, 1.0-7.0%) were asymptomatic CRAG-positive. Positive results cases were cross-verified by performing LFA in whole blood.
CONCLUSIONS: 3.1% of HIV-infected inpatients with CD4 <200 cells/μl without symptomatic meningitis had cryptococcal antigenemia in São Paulo, suggesting that routine CRAG screening may be beneficial in similar settings in South America. Our study reveals another targeted population for CRAG screening: hospitalised HIV-infected patients with CD4 <200 cells/μl, regardless of ART status. Whole blood CRAG LFA screening seems to be a simple strategy to prevention of symptomatic meningitis.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Criptococo; Cryptococcus; HIV/AIDS; VIH/SIDA; cribado criptocócico; cryptococcal meningitis; cryptococcal polysaccharide; cryptococcal screening; dépistage cryptococcique; meningitis criptocócica; méningite cryptococcique; polisacárido criptocócico; polysaccharide cryptococcique; prevalence; prevalencia; prévalence

Mesh:

Substances:

Year:  2016        PMID: 27699970     DOI: 10.1111/tmi.12790

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  10 in total

1.  Should we perform the serum cryptococcal antigen test in people living with HIV hospitalized due to a community-acquired pneumonia episode?

Authors:  Adriana Paulino Silva; Carolina Toniolo Zenatti; Claudia Figueiredo-Mello; Marinella Della Negra; Anna S Levin; David R Boulware; José Ernesto Vidal
Journal:  Int J STD AIDS       Date:  2020-02-23       Impact factor: 1.359

2.  Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in Tanzania.

Authors:  Diana Faini; Aneth Vedastus Kalinjuma; Andrew Katende; Gladys Mbwaji; Dorcas Mnzava; Amina Nyuri; Tracy R Glass; Hansjakob Furrer; Christoph Hatz; David R Boulware; Emilio Letang
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

3.  High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.

Authors:  João Guilherme Pontes Lima Assy; Renato do Carmo Said; Olivia Campos Pinheiro; Alisson Dos Santos Brandão; David R Boulware; Francisco Oscar de Siqueira França; José Ernesto Vidal
Journal:  Med Mycol       Date:  2021-09-03       Impact factor: 4.076

4.  MLST reveals a clonal population structure for Cryptococcus neoformans molecular type VNI isolates from clinical sources in Amazonas, Northern-Brazil.

Authors:  Diego Fernando Silva Rocha; Katia Santana Cruz; Carla Silvana da Silva Santos; Lizandra Stephanny Fernandes Menescal; João Ricardo da Silva Neto; Silviane Bezerra Pinheiro; Lucyane Mendes Silva; Luciana Trilles; João Vicente Braga de Souza
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

5.  Prevalence of Cryptococcal Antigen and Outcomes in People With Human Immunodeficiency Virus in Honduras: A Cohort Study.

Authors:  Julio C Zuniga-Moya; Luis Enrique Romero-Reyes; Emilio Barrueto Saavedra; Sandra Montoya; Diana Varela; Mitchel Borjas; Alicia Cerna; Suyapa Bejarano; Paola Martinez; Karen Lujan; Karen Erazo; Isis Lainez; Luisamaria Pineda; David Yanes; Jane A O'Halloran; Andrej Spec
Journal:  Open Forum Infect Dis       Date:  2020-11-13       Impact factor: 3.835

6.  Epidemiology and Mortality of Cryptococcal Disease in Guatemala: Two-Year Results of a Cryptococcal Antigen Screening Program.

Authors:  Narda Medina; Juan Luis Rodriguez-Tudela; Juan Carlos Pérez; Danicela Mercado; Oscar Bonilla; Eduardo Arathoon; Ana Alastruey-Izquierdo
Journal:  Microorganisms       Date:  2022-07-10

7.  Evaluation of a Cryptococcal Antigen Lateral Flow Assay and Cryptococcal Antigen Positivity at a Large Public Hospital in Atlanta, Georgia.

Authors:  Kristin R V Harrington; Yun F Wang; Paulina A Rebolledo; Zhiyong Liu; Qianting Yang; Russell R Kempker
Journal:  Open Forum Infect Dis       Date:  2021-03-12       Impact factor: 3.835

Review 8.  The status of cryptococcosis in Latin America.

Authors:  Carolina Firacative; Jairo Lizarazo; María Teresa Illnait-Zaragozí; Elizabeth Castañeda
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-04-05       Impact factor: 2.743

9.  CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.

Authors:  Nathan Ford; Zara Shubber; Joseph N Jarvis; Tom Chiller; Greg Greene; Chantal Migone; Marco Vitoria; Meg Doherty; Graeme Meintjes
Journal:  Clin Infect Dis       Date:  2018-03-04       Impact factor: 9.079

10.  Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia.

Authors:  Miaomiao Xu; Zhihang Peng; Chuanjun Xu; Yaling Chen; Jian Cheng; Yun Chi; Hongxia Wei; Wei Chen; Zhiliang Hu
Journal:  Front Cell Infect Microbiol       Date:  2020-04-24       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.